Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111233795B reveals organic catalytic method. High yield and stereoselectivity ensure reliable supply chain for antitumor drug manufacturing.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.
Novel asymmetric dearomatization method for chiral benzofurans with high enantioselectivity. Offers cost-effective routes for pharmaceutical intermediates.
Patent CN110256479B reveals a novel Ag/Cu-catalyzed route to chiral silicon pyrrolidines. Discover high-ee synthesis, mild conditions, and scalable manufacturing advantages.
Novel chiral auxiliary method for Tapentadol intermediates. High purity, scalable process reducing costs and lead time for pharmaceutical manufacturing supply chains.
Novel silver catalyst enables high-yield asymmetric synthesis for pharmaceutical intermediates with improved supply chain reliability and cost efficiency.
Novel iridium-catalyzed asymmetric synthesis offers high ee values. Enhances supply chain reliability for pharmaceutical intermediates manufacturing. Supports commercial scale-up of complex pharmaceutical intermediates with stringent purity.
Patent CN105732631A reveals efficient N9 vinyl purine synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with high yield and scalability.
Patent CN116589426B reveals iridium-catalyzed asymmetric synthesis enabling high-purity chiral intermediates with significant supply chain and cost advantages for global pharmaceutical manufacturing.
Novel iridium catalyzed asymmetric synthesis offers high enantioselectivity. Reduces costs and improves supply chain reliability for pharmaceutical intermediates globally.
Patent CN115286635A details a metal-free asymmetric synthesis of chiral pyrazolones with high ee. Offers cost-effective manufacturing for pharmaceutical intermediates.
Patent CN111233795A details a novel organocatalytic route to chiral gamma-butyrolactones with high stereoselectivity, offering cost-effective API intermediate manufacturing solutions.
Patent CN108558882B reveals a novel [3+2] cycloaddition route for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN104788370B enables configuration-controlled synthesis of chiral intermediates. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN116589426A details Ir-catalyzed asymmetric [4+2]-cycloaddition. Offers high ee, mild conditions for scalable pharmaceutical intermediate manufacturing.
Patent CN114591344B reveals a Pd-catalyzed synthesis for chiral spiro compounds. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Novel iridium-catalyzed synthesis offers high purity and cost efficiency for pharmaceutical intermediates. Enhances supply chain reliability for anti-colon cancer drug development.
Patent CN116589426B details a novel iridium-catalyzed asymmetric [4+2]-cycloaddition for high-purity chiral 1,3-benzoxazine intermediates, offering mild conditions and supply chain reliability.
Patent CN101492407B details a mild organocatalytic route for high-purity beta-indolaldehyde, offering significant cost and environmental benefits for pharma manufacturing.
Patent CN116375653A details a high enantioselective iridium-catalyzed method for chiral tetrahydroquinazoline derivatives, offering cost-effective API intermediate manufacturing solutions.